Singapore markets closed

Cytokinetics, Incorporated (CYTK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
60.20+0.06 (+0.10%)
As of 09:47AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
3,752
7,530
94,588
70,428
55,828
-
Cost of revenue
332,272
330,123
240,813
159,938
96,951
-
Gross profit
-328,520
-322,593
-146,225
-89,510
-41,123
-
Operating expenses
Research development
-
-
-
159,938
96,951
86,125
Selling general and administrative
169,447
173,612
177,977
96,803
52,820
-
Total operating expenses
169,447
173,612
177,977
96,803
52,820
-
Operating income or loss
-497,967
-496,205
-324,202
-186,313
-93,943
-
Interest expense
61,748
57,668
51,156
29,332
38,676
-
Total other income/expenses net
-
-
-24,939
-
-
-
Income before tax
-530,598
-526,244
-388,955
-215,314
-127,290
-
Income from continuing operations
-530,598
-526,244
-388,955
-215,314
-127,290
-
Net income
-530,598
-526,244
-388,955
-215,314
-127,290
-
Net income available to common shareholders
-530,598
-526,244
-388,955
-215,314
-127,290
-
Basic EPS
-2.80
-5.45
-4.33
-2.80
-1.97
-
Diluted EPS
-2.80
-5.45
-4.33
-2.80
-1.97
-
Basic average shares
76,886
96,524
89,825
76,886
64,524
-
Diluted average shares
76,886
96,524
89,825
76,886
64,524
-